Method for simultaneously detecting curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium

Through high performance liquid chromatography combined with electrospray detector, simultaneous determination of curcumin, chondroitin sulfate, glucose hydrochloride and calcium were achieved, solving the problems of multiple independent experiments in the prior art and improving the detection efficiency and accuracy , simplifies the sample processing process.

CN119000930APending Publication Date: 2024-11-22GUANGZHOU HANFANG PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411115151.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the prior art, multiple independent experiments are required when detecting curcumin, chondroitin sulfate, glucose hydrochloride and calcium. The sample pre-processing is cumbersome, the analysis time is long, the operability is not strong, and an authoritative method for simultaneous determination is lacking.

Method used

Using high performance liquid chromatography combined with electrospray detector, the simultaneous separation and determination of curcumin, chondroitin sulfate, glucose hydrochloride and calcium are achieved through the combination of gradient elution procedures and specific mobile phases, using hydrophilic chromatography columns and gradients Elution procedure ensures baseline separation of principal components from impurity peaks and accurate quantities.

Benefits of technology

It simplifies sample preprocessing, shortens analysis time, improves detection efficiency, and realizes fast and accurate detection of four components, is simple to operate and has high safety, and reduces the configuration requirements for the detection equipment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119000930A_ABST
    Figure CN119000930A_ABST
Patent Text Reader

Abstract

The invention provides a method for simultaneously detecting curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium, and relates to the technical field of analysis. According to the detection method, an acetonitrile-water-trifluoroacetic acid mixed solvent is used as a mobile phase A, an acetonitrile-water-ammonium acetate mixed solvent is used as a mobile phase B, a hydrophilic interaction chromatographic column is used as a stationary phase, and a reversed-phase liquid chromatography system is matched with an electrospray detector to serve as a means for separating and detecting target components. The method can be used for simultaneously determining four components, namely curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium. According to the method, the problem that in the prior art, the contents of the four functional components can be determined only through multiple devices and multiple tests is solved. According to the method, the peak pattern of each component is good, the separation degree meets the specification, and data support and reference are provided for quality standard formulation of products and rapid screening of preparation processes.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of analytical technology, in particular to a method for simultaneously detecting curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium. Background Art

[0002] The following statements merely provide background information related to the present disclosure and do not necessarily constitute prior art.

[0003] There is currently no authoritative test method for the simultaneous determination of curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium. If the determination of the above four components is required, they must be determined separately according to multiple standard documents, as follows:

[0004] For curcumin, according to SN / T 4890-2017 Determination of curcumin in exported food: high performance liquid chromatography and liquid chromatography-mass spectrometry / mass spectrometry are used, and the HPLC-UV method is used to extract curcumin in the sample with methanol-water solution, and the sample solution is cleaned up using a solid phase extraction column as needed, and quantified by the external standard method.

[0005] For chondroitin sulfate and glucosamine hydrochloride, according to GB / T 20365-2006 Determination of chondroitin sulfate and glucosamine hydrochloride content: liquid chromatography, the HPLC-UV method was used to determine the contents of the two. The inventor used this method to perform sample pretreatment and liquid phase determination on glucosamine chondroitin calcium tablets, and found that the retention time of chondroitin sulfate in this method was only 1.9 minutes, and the retention time of glucosamine hydrochloride was only 2.5 minutes, both of which were relatively short. For the chromatogram of the blank solvent (10% acetonitrile aqueous solution) of this method, there was an inverted peak of the solvent peak at 2.5 minutes, which interfered with the main peak of chondroitin sulfate. For details, see the attached Figure 1 , so when the concentration of chondroitin sulfate in the sample solution is low, its accuracy is low.

[0006] Regarding calcium content, according to GB 5009.92-2016 National Food Safety Standard: Determination of Calcium in Food, the sample is digested using nitric acid and a microwave digester, and then the calcium content is determined using an ICP-OES or atomic absorption spectrometer. Nitric acid is an explosive reagent with low safety, and both purchase and post-use processing require a special filing process.

[0007] In summary, the determination of four components, namely curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium, requires the use of multiple testing equipment and three independent experiments. This operation results in cumbersome sample pretreatment, long analysis time and poor operability. Therefore, in order to ensure the quality of products containing four components, namely curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium, and to timely monitor the quality of intermediate products and finished products, it is urgent to establish a method for simultaneously determining the four functional components of the product.

[0008] In view of this, the present invention is proposed. Summary of the invention

[0009] The object of the present invention is to provide a method for simultaneously detecting curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium, so as to alleviate the problem that the detection of the above four components in the prior art requires multiple experimental equipment and multiple independent experiments to complete the detection of the four functional components, thereby improving the detection efficiency and providing a more scientific basis for controlling product quality. Another object of the present invention is to provide an application of the above detection method.

[0010] In order to solve the above technical problems, the present invention particularly adopts the following technical solutions:

[0011] In a first aspect, a method for simultaneously detecting curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium is provided, the method comprising separating curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium by high performance liquid chromatography;

[0012] HPLC conditions included:

[0013] The chromatographic column uses a chromatographic column whose stationary phase has a hydrophilic effect;

[0014] The mobile phase system includes mobile phase A and mobile phase B;

[0015] The mobile phase A is composed of acetonitrile, water and trifluoroacetic acid, and the concentrations of acetonitrile, water and trifluoroacetic acid in the mobile phase A are equivalent to the concentrations of acetonitrile, water and trifluoroacetic acid in a system in which acetonitrile and 0.15% v / v trifluoroacetic acid aqueous solution are mixed in a volume ratio of (75-80): (20-25);

[0016] The mobile phase B is composed of acetonitrile, water and ammonium acetate, and the concentrations of acetonitrile, water and ammonium acetate in the mobile phase B are equivalent to the concentrations of acetonitrile, water and ammonium acetate in a system in which acetonitrile and 0.5% w / v ammonium acetate aqueous solution are mixed in a volume ratio of (15-20):(75-85);

[0017] According to the gradient elution, the elution program is:

[0018] At 0 to 2 minutes, the initial volume ratio of the mobile phase A to the mobile phase B is (90 to 99): (1 to 10);

[0019] At 2.1-7 min, the volume ratio of the mobile phase A to the mobile phase B changes from (90-99):(1-10) to (70-75):(25-30);

[0020] At 7.1-12 min, the volume ratio of the mobile phase A to the mobile phase B changes from (70-75):(25-30) to (90-99):(1-10);

[0021] At 12.1-18 min, the volume ratio of the mobile phase A to the mobile phase B is maintained at (90-99):(1-10);

[0022] The detector of the liquid chromatograph is an electrospray detector.

[0023] In a second aspect, there is provided application of the method for simultaneously detecting curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium in the first aspect in the preparation of a nutritional supplement.

[0024] Compared with the prior art, the present invention has the following beneficial effects:

[0025] (1) A method for simultaneously determining the contents of four components, namely, curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium, in a sample using HPLC-CAD (high performance liquid chromatography-electrospray ionization detector) is disclosed for the first time.

[0026] (2) A hydrophilic interaction chromatography column was used as the analytical column and a CAD detector was used as the detection method to achieve simultaneous determination of four components: curcumin, chondroitin sulfate, glucosamine hydrochloride, and calcium. The main component and impurity peaks were baseline separated and accurately quantified.

[0027] (3) Compared with the prior art, the present invention has simple pre-treatment and accurate analysis results, can realize rapid detection and quality control of intermediate products and finished products, shortens the analysis time, is simple to operate, has high safety, and has low requirements for the configuration of detection equipment. It only needs to use a high performance liquid chromatograph with a CAD detector, and can be promoted and applied. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0029] Figure 1 Chromatograms of blank solvent and test solution for determination of chondroitin sulfate and glucosamine hydrochloride according to GB / T 20365-2006;

[0030] Figure 2 The specific chromatograms of the detection method of Example 1 for detecting the auxiliary material sample solution, the reference substance mixture and the test solution;

[0031] Figure 3 is the chromatogram of the evaporative light scattering detector of Example 4;

[0032] Figure 4 This is the chromatogram of chromatographic column No. 2 in Example 5;

[0033] Figure 5 This is the chromatogram of chromatographic column No. 3 in Example 5;

[0034] Figure 6 This is the chromatogram of chromatographic column No. 4 in Example 5;

[0035] Figure 7 This is the chromatogram when the acid type in the pretreatment of Example 6 is hydrochloric acid. DETAILED DESCRIPTION

[0036] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments. Obviously, the described embodiments are part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0037] In a first aspect, a method for simultaneously detecting curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium is provided, the method comprising separating curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium by high performance liquid chromatography.

[0038] HPLC conditions included:

[0039] The chromatographic column uses a chromatographic column with a hydrophilic stationary phase.

[0040] In an optional embodiment, the chromatographic column is a YMC-Triart Diol-HILIC liquid chromatography column with a specification of 4.6×250 mm and 5 μm.

[0041] The mobile phase system includes mobile phase A and mobile phase B:

[0042] Mobile phase A consists of acetonitrile, water and trifluoroacetic acid. The concentrations of acetonitrile, water and trifluoroacetic acid in mobile phase A are equivalent to the concentrations of acetonitrile, water and trifluoroacetic acid in a system in which acetonitrile and 0.15% v / v trifluoroacetic acid aqueous solution are mixed in a volume ratio of (75-80):(20-25). The volume ratio of acetonitrile and 0.15% v / v trifluoroacetic acid aqueous solution can be, for example but not limited to, 75:25, 75:20, 80:20, 80:25, 75:22, 80:22, 78:20 or 78:25. It is to be understood that the present invention does not require the use of 0.15% v / v trifluoroacetic acid aqueous solution for preparation in actual preparation. Acetonitrile, water and trifluoroacetic acid in mobile phase A can be prepared in any order, as long as the final concentration of each component is consistent with the system prepared by mixing acetonitrile and 0.15% v / v trifluoroacetic acid aqueous solution in a volume ratio of (75-80): (20-25).

[0043] Mobile phase B is composed of acetonitrile, water and ammonium acetate. The concentrations of acetonitrile, water and ammonium acetate in mobile phase B are equivalent to the concentrations of acetonitrile, water and ammonium acetate in a system where acetonitrile and 0.5% w / v ammonium acetate aqueous solution are mixed in a volume ratio of (15-20): (75-85). The volume ratio of acetonitrile and 0.5% w / v ammonium acetate aqueous solution can be, for example, but not limited to, 15:85, 20:85, 15:75, 20:75, 18:75, 18:85, 15:80 or 20:80. It is understood that the present invention does not require the use of 0.5% w / v ammonium acetate aqueous solution for configuration in actual preparation. Acetonitrile, water and ammonium acetate in mobile phase B can be prepared in any order, as long as the final concentration of each component is consistent with the system where acetonitrile and 0.5% w / v ammonium acetate aqueous solution are mixed in a volume ratio of (15-20): (75-85).

[0044] In an optional embodiment, mobile phase A consists of acetonitrile, water and trifluoroacetic acid, and the concentrations of acetonitrile, water and trifluoroacetic acid in mobile phase A are equivalent to the concentrations of acetonitrile, water and trifluoroacetic acid in a system in which acetonitrile and 0.15% v / v trifluoroacetic acid aqueous solution are mixed in a volume ratio of 78:22.

[0045] In an optional embodiment, mobile phase B consists of acetonitrile, water and ammonium acetate, and the concentrations of acetonitrile, water and ammonium acetate in mobile phase B are equivalent to the concentrations of acetonitrile, water and ammonium acetate in a system in which acetonitrile and 0.5% w / v ammonium acetate aqueous solution are mixed in a volume ratio of 20:80.

[0046] In an optional embodiment, mobile phase A consists of acetonitrile and 0.15% v / v trifluoroacetic acid aqueous solution, and the volume ratio of acetonitrile and 0.15% v / v trifluoroacetic acid aqueous solution is 78:22; mobile phase B consists of acetonitrile and 0.5% w / v ammonium acetate aqueous solution, and the volume ratio of acetonitrile and 0.5% w / v ammonium acetate aqueous solution is 20:80.

[0047] According to the gradient elution, the elution program is:

[0048] At 0 to 2 minutes, the initial volume ratio of the mobile phase A to the mobile phase B is (90 to 99): (1 to 10);

[0049] At 2.1-7 min, the volume ratio of the mobile phase A to the mobile phase B changes from (90-99):(1-10) to (70-75):(25-30);

[0050] At 7.1-12 min, the volume ratio of the mobile phase A to the mobile phase B changes from (70-75):(25-30) to (90-99):(1-10);

[0051] At 12.1 to 18 min, the volume ratio of the mobile phase A to the mobile phase B was maintained at (90 to 99): (1 to 10).

[0052] In an optional embodiment, according to gradient elution, the elution procedure is:

[0053] At 0 to 2 minutes, the initial volume ratio of the mobile phase A to the mobile phase B is 95:5;

[0054] At 2.1 to 7 minutes, the volume ratio of the mobile phase A to the mobile phase B changed from 95:5 to 72:28;

[0055] At 7.1 to 12 minutes, the volume ratio of the mobile phase A to the mobile phase B changed from 72:28 to 95:5;

[0056] From 12.1 to 18 min, the volume ratio of the mobile phase A to the mobile phase B was maintained at 95:5.

[0057] In an optional embodiment, the volume ratio of the mobile phase A to the mobile phase B in any step changes at a linear uniform speed.

[0058] In an optional embodiment, the volume ratio of mobile phase A to mobile phase B in all steps changes at a linear uniform speed.

[0059] The detector of the liquid chromatograph is an electrospray detector. The electrospray detector (CAD detector) is a general-purpose detector with the advantages of high sensitivity and good reproducibility. It can detect most non-volatile and semi-volatile compounds. The analyte does not require a chromophore or ionization. Its sensitivity and equipment stability are higher than those of the evaporative light detector (ELSD detector).

[0060] In an optional embodiment, the parameters of the electrospray detector are: data acquisition frequency 10 Hz, filtering 5.0 s, control of nebulizer temperature High, power function 1, and gas pressure of 65.2 psi.

[0061] In an optional embodiment, the flow rate of the gradient elution is 0.9-1.1 mL / min, for example, but not limited to, 0.9, 1, 1.1 mL / min.

[0062] In an optional embodiment, the injection volume is 10 μL.

[0063] In an optional embodiment, the column temperature of the chromatographic column is 38-42°C, for example, but not limited to, 38, 40 or 42°C, preferably 40°C.

[0064] In an optional embodiment, the method includes analyzing and calculating the contents of curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium by an external standard method;

[0065] In an optional embodiment, the external standard method is a standard curve method.

[0066] In an optional embodiment, the method includes recording a chromatogram after gradient elution, performing qualitative analysis based on the retention time of curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium reference substances, obtaining the concentrations of curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium in the test solution from the standard curve, and calculating their respective contents based on the sample weight and the dilution factor.

[0067] In an optional embodiment, the sample to be tested includes a nutritional supplement containing curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium.

[0068] In an optional embodiment, the sample to be tested includes the Glucosamine chondroitin calcium tablets. It is made of calcium carbonate, D-glucosamine hydrochloride, chondroitin sulfate and curcumin as raw materials; low-substituted hydroxypropyl cellulose, povidone K30, microcrystalline cellulose and other auxiliary materials, and is processed through main processes such as mixing, granulation, drying, tableting, coating and packaging. It is a health food with the function of increasing bone density.

[0069] In an optional embodiment, the nutritional supplement is a tablet, and the auxiliary materials include low-substituted hydroxypropyl cellulose, povidone K30 and microcrystalline cellulose.

[0070] In an optional embodiment, the calcium in the sample to be tested is provided by calcium carbonate, and the method further comprises pre-treating the sample, wherein the pre-treatment comprises extracting the analyte in the sample to be tested using an extraction reagent; the extraction reagent comprises an organic phase, an acid and water.

[0071] The pretreatment is simple, and the sample only needs to be added with an appropriate solvent for extraction. The extraction of the four active ingredients can be completed without solid phase column purification and derivatization reaction.

[0072] In an optional embodiment, the organic phase comprises one or more of ethanol, methanol and acetonitrile;

[0073] In an optional embodiment, the organic phase comprises 95% v / v ethanol;

[0074] In an optional embodiment, the acid includes one or more of glacial acetic acid, phosphoric acid and hydrochloric acid;

[0075] In an optional embodiment, the extraction reagent includes 95% v / v ethanol, glacial acetic acid and water, and the ratio of the test sample, 95% v / v ethanol, glacial acetic acid and water is 0.15 g: 20-50 mL: 2-4 mL: 50 mL.

[0076] In an optional embodiment, the ratio of the test sample to 95% v / v ethanol is 0.15 g:30 mL.

[0077] In an optional embodiment, the ratio of the sample to be tested to glacial acetic acid is 0.15 g:2 mL.

[0078] In an optional embodiment, the pretreatment includes mixing the sample to be tested with the organic phase, adding acid and water, extracting by shaking, filtering and collecting the filtrate to obtain the test solution.

[0079] In an optional embodiment, the pretreatment includes weighing the sample, placing it in a volumetric flask, adding an organic phase to mix the sample, adding acid, adding water, shaking and extracting, bringing to room temperature, making up to volume with water, shaking, letting it stand, filtering and taking the filtrate to obtain the test solution.

[0080] In an optional embodiment, the vibration extraction is ultrasonic extraction.

[0081] In an optional embodiment, the output power of the ultrasonic extraction is 500w and the time is 5min.

[0082] In a second aspect, the invention also provides the use of the method for simultaneously detecting curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium in the first aspect in the preparation of a nutritional supplement.

[0083] In an optional embodiment, the nutritional supplement contains curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium.

[0084] In an optional embodiment, the calcium of the nutritional supplement is provided by calcium carbonate.

[0085] In an optional embodiment, the nutritional supplement is a tablet, and the auxiliary materials include low-substituted hydroxypropyl cellulose, povidone K30 and microcrystalline cellulose.

[0086] In an optional embodiment, the nutritional supplement is produced by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. Glucosamine Chondroitin Calcium Tablets. Taking into account the product's health function and the correlation between the raw material ingredients, the product selects curcumin, chondroitin sulfate, glucosamine hydrochloride, and calcium as the signature ingredients to control product quality.

[0087] The present invention is further described below by means of specific examples. However, it should be understood that these examples are only used for more detailed description and should not be construed as limiting the present invention in any form.

[0088] Reference substances and samples in the following examples: chondroitin sulfate (Yuanye Technology, batch number O231Y229709, content: 95.0%), D-glucosamine hydrochloride (China Food and Drug Administration, batch number 140649-202208, content: 99.9%), curcumin (China Food and Drug Administration, batch number 110823-202107, content: 98.1%), calcium standard solution (Gangyan Nanogram, batch number 22122125 concentration: 1000 μg / mL), Glucosamine chondroitin calcium tablets (Batch numbers: S240102, S240125, S240126-1, S240126-2).

[0089] Example 1

[0090] This embodiment provides a method for simultaneously determining four functional ingredients in glucosamine chondroitin calcium tablets using HPLC-CAD method, wherein the four functional ingredients include glucosamine hydrochloride, chondroitin sulfate, calcium and curcumin. The method comprises the following steps:

[0091] (I) Preparation of test solution: Take 30 tablets of glucosamine chondroitin calcium tablets, place them in a mortar and grind them into uniform powder, accurately weigh 0.15 g, place them in a 100 mL volumetric flask, add 30 mL of 95% ethanol, shake gently to disperse the sample evenly, add 2 mL of glacial acetic acid and 50 mL of water, shake gently, extract with ultrasound (500w, 5min), take out and let it cool to room temperature, make up to volume with water, shake well, let it stand for 15 min, take the supernatant and filter it with a 0.45μm filter membrane to obtain the sample test solution.

[0092] (II) HPLC conditions:

[0093] Mobile phase: A mixed solvent of acetonitrile-0.15% trifluoroacetic acid in a volume ratio of 78:22 was used as mobile phase A, and a mixed solvent of acetonitrile-0.5% ammonium acetate aqueous solution in a volume ratio of 20:80 was used as mobile phase B, and gradient elution was performed.

[0094] Gradient elution: at 0-2 min, the initial volume ratio of mobile phase A to mobile phase B was 95:5; at 2.1-7 min, the volume ratio of mobile phase A to mobile phase B changed linearly and uniformly from 95:5 to 72:28; at 7.1-12 min, the volume ratio of mobile phase A to mobile phase B changed linearly and uniformly from 72:28 to 95:5; at 12.1-18 min, the volume ratio of mobile phase A to mobile phase B remained at 95:5.

[0095] Chromatographic column: YMC-Triart Diol-HILIC (YMC, size 4.6×250mm, 5μm)

[0096] Detector: CAD detector.

[0097] CAD related parameters: data acquisition frequency 10Hz, filtering 5.0s, control atomizer temperature High, power function 1, air pressure 65.2psi.

[0098] Flow rate: 1.0mL / min.

[0099] Injection volume: 10 μL.

[0100] Column temperature: 40℃.

[0101] Instruments: High performance liquid chromatograph (Thermo U3000) with CAD detector.

[0102] (III) Preparation of standard curve solution:

[0103] The concentrations of the analytes in each standard curve are shown in Table 1, and the preparation method is as follows:

[0104] A. Accurately weigh 30 mg of curcumin reference substance, dissolve it in 95% ethanol to 10 mL, and obtain a curcumin stock solution with a concentration of 3 mg / mL; accurately weigh 60 mg of chondroitin sulfate reference substance, dissolve it in water to 10 mL, and obtain a chondroitin sulfate stock solution with a concentration of 6 mg / mL; accurately weigh 20 mg of D-glucosamine hydrochloride reference substance, place it in a 10 mL volumetric flask, accurately add 1.0 mL of curcumin stock solution, 1.0 mL of chondroitin sulfate stock solution, and 6.0 mL of 1 mg / mL calcium standard solution to the volumetric flask, and dilute to the scale with water to obtain a reference substance mixture with a curcumin concentration of 0.3 mg / mL, a chondroitin sulfate concentration of 0.6 mg / mL, a glucosamine hydrochloride concentration of 2.0 mg / mL, and a calcium concentration of 0.6 mg / mL, as the standard curve solution V.

[0105] B. Accurately pipette 1.0 mL of the standard curve solution V, dilute it to 2 mL with a blank solvent (95% ethanol-glacial acetic acid-water = 15:1:34), and obtain a reference solution with a curcumin concentration of 0.15 mg / mL, a chondroitin sulfate concentration of 0.3 mg / mL, a glucosamine hydrochloride concentration of 1.0 mg / mL, and a calcium concentration of 0.3 mg / mL as the standard curve solution IV.

[0106] C. Accurately pipette 1.0 mL of the standard curve solution IV, dilute it to 2 mL with the blank solvent (95% ethanol-glacial acetic acid-water = 15:1:34), and obtain a reference solution with a curcumin concentration of 0.075 mg / mL, a chondroitin sulfate concentration of 0.15 mg / mL, a glucosamine hydrochloride concentration of 0.5 mg / mL, and a calcium concentration of 0.15 mg / mL as the standard curve solution III.

[0107] D. Accurately pipette 1.0 mL of the standard curve solution III, dilute it to 2 mL with the blank solvent (95% ethanol-glacial acetic acid-water = 15:1:34), and obtain a reference solution with a curcumin concentration of 0.038 mg / mL, a chondroitin sulfate concentration of 0.075 mg / mL, a glucosamine hydrochloride concentration of 0.25 mg / mL, and a calcium concentration of 0.075 mg / mL as the standard curve solution II.

[0108] E. Accurately pipette 1.0 mL of the standard curve solution II and dilute it to 2 mL with the blank solvent (95% ethanol-glacial acetic acid-water = 15:1:34) to obtain a reference solution with a curcumin concentration of 0.019 mg / mL, a chondroitin sulfate concentration of 0.038 mg / mL, a glucosamine hydrochloride concentration of 0.13 mg / mL, and a calcium concentration of 0.038 mg / mL as the standard curve solution I.

[0109] Table 1

[0110]

[0111] (IV) Reference substance mixture: Take the above standard curve solution II as the reference substance mixture.

[0112] (V) Preparation of excipient sample solution: Take the excipient sample and prepare it according to the above scheme (I).

[0113] (VI) Take 10 μL of blank solvent (95% ethanol-glacial acetic acid-water = 15:1:34), auxiliary material sample solution, standard curve solution I to standard curve solution V, and test solution respectively, and inject into the chromatograph to record the chromatogram according to the chromatographic conditions in the technical plan. Perform qualitative analysis based on the retention time of curcumin, chondroitin sulfate, glucosamine hydrochloride, and calcium reference substances. The concentrations of curcumin, chondroitin sulfate, glucosamine hydrochloride, and calcium in the test solution are obtained from the standard curve, thereby calculating the corresponding content of each component. The specificity spectrum of the auxiliary material sample solution, the reference substance mixture, and the test solution is shown in the figure below. Figure 2 shown.

[0114] Example 2

[0115] Methodological validation

[0116] (I) Specificity and system suitability experiments

[0117] Accurately take 10 μL each of blank solvent (95% ethanol-glacial acetic acid-water = 15:1:34), the excipient sample solution prepared in Example 1, the test solution, the reference mixed solution and the sample spiked solution, and perform the determination according to the technical scheme described in Example 1.

[0118] The determination results show that the blank solvent (95% ethanol-glacial acetic acid-water = 15:1:34) and the auxiliary sample solution do not interfere with the main peak determination of the four components. There is no interference near the main peak of the reference mixed standard solution, the test solution and the sample spiked solution, and the retention time of the main peak is known, indicating that the specificity of the method meets the requirements; based on the chromatogram and peak area of ​​the reference mixed standard solution obtained by continuous injection of 6 times, the RSD and separation degree of each component peak were calculated. The experimental results are shown in Table 2.

[0119] Table 2 System suitability experimental data

[0120]

[0121] (II) Detection limit and quantification limit

[0122] Curcumin, chondroitin sulfate, D-glucosamine hydrochloride, and calcium standard solutions were prepared into solutions with a signal-to-noise ratio of about 10:1 as quantitative limit control solutions; solutions with a signal-to-noise ratio of about 3:1 were prepared as detection limit control solutions, and the samples were injected and measured according to the chromatographic conditions in the technical scheme of Example 1, and the chromatograms were recorded. The quantitative limits and detection limits of each component were measured as shown in Table 3.

[0123] Table 3 Detection limit and quantification limit experimental data

[0124] Components Curcumin Chondroitin Sulfate D-Glucosamine Hydrochloride calcium Detection limit 0.08μg 0.015 μg 0.023 μg 0.018μg Limit of Quantitation 0.024 μg 0.045 μg 0.068μg 0.048 μg

[0125] (III) Linear relationship test

[0126] According to the chromatographic conditions in the technical scheme of Example 1, 10 μL of each of the standard solutions I to V were accurately drawn and injected into the liquid chromatograph, and the peak area of ​​each component was used as the ordinate and the concentration of each component was used as the abscissa to calculate the regression equation. From the measurement results, it is known that the standard curve equation of curcumin is y=184.2584x+0.1587, and the correlation coefficient R 2 =0.9999; the standard curve equation of chondroitin sulfate is y=12.8925x+0.1052, and the correlation coefficient is R 2 =0.9998; the standard curve equation of D-glucosamine hydrochloride is y=12.4102x-0.1003, and the correlation coefficient R 2 =1.0000; the standard curve equation of calcium is y=43.0722x+0.0052, and the correlation coefficient is R 2 =0.9997, indicating that in the method of Example 1, a good linear relationship can be presented for these four components.

[0127] (IV) Precision test

[0128] Take S240102 batch of glucosamine chondroitin calcium tablets, prepare 6 test solutions in parallel according to the conditions in the technical scheme of Example 1, take curcumin, chondroitin sulfate, D-glucosamine hydrochloride, and calcium standard solutions to prepare standard solutions I to standard solutions V according to the method described, and inject and measure in sequence according to the chromatographic conditions described, record the chromatogram, and calculate the concentrations of curcumin, chondroitin sulfate, D-glucosamine hydrochloride, and calcium in the samples according to the 4 measured standard curves, respectively, and then calculate the content, content mean, and relative standard deviation (RSD) of each component. The results are shown in Table 4. According to the measured values, the precision of the four components meets the requirements.

[0129] Table 4 Precision test results (unit: g / 100g)

[0130] Components 1 2 3 4 5 6 Content mean RSD Curcumin 5.31 5.28 5.35 5.40 5.27 5.33 5.3 0.9% Chondroitin Sulfate 10.72 10.75 10.80 10.81 10.68 10.65 10.7 0.6% Glucosamine Hydrochloride 37.66 37.65 37.48 34.65 37.42 37.52 37.1 3.2% calcium 9.85 9.97 9.95 10.01 10.10 9.95 10.0 0.8%

[0131] (V) Accuracy test

[0132] According to the three levels of 80%, 100%, and 120% (low, medium, and high), take the S240102 batch of glucosamine chondroitin calcium tablets, accurately weigh 0.15g of the sample, put it in a 200mL volumetric flask, and prepare 9 copies in parallel, numbered 1 to 9. Take the low-level inspection samples (samples 1 to 3), and accurately add curcumin, chondroitin sulfate, and D-glucosamine hydrochloride reference substance 6.39mg, 12.88mg, and 44.48mg in sequence; take the medium-level inspection samples (samples 4 to 6), and accurately add curcumin, chondroitin sulfate, and D-glucosamine hydrochloride reference substance 8.01mg, 16.12mg, and 55.92mg in sequence; take the high-level inspection samples (samples 7 to 9), and accurately add curcumin, chondroitin sulfate, and D-glucosamine hydrochloride reference substance 9.82mg, 19.95mg, and 66.82mg in sequence. 9 samples were added with 60 mL of 95% ethanol, shaken gently to make the samples dispersed evenly, 4 mL of glacial acetic acid; 12.0 mL of calcium standard solution was added to low-level samples, 15.0 mL of calcium standard solution was added to medium-level samples, and 18.0 mL of calcium standard solution was added to high-level samples, and then about 100 mL of water was added. After shaking gently, ultrasonic extraction (500w, 5min) was performed, taken out and placed at room temperature, fixed to volume with water, shaken, and allowed to stand for 15min. The supernatant was filtered with a 0.45μm filter membrane to obtain the sample test solution. The samples were measured according to the chromatographic conditions, the chromatograms were recorded, the actual measurements of each component were calculated, and the accuracy data were converted according to the amount of addition. The experimental results are shown in Table 5.

[0133] Table 5 Accuracy test results

[0134]

[0135] Example 3

[0136] Comparison of different mobile phases and elution conditions:

[0137] The reference substance mixture in step (iv) of Example 1 was tested according to the mobile phase and elution conditions recorded in Table 6, and the remaining chromatographic conditions were the chromatographic conditions in step (ii) of Example 1. The results are shown in Table 6.

[0138] According to the preparation of the reference substance mixture (iv) in Example 1, a mixed solvent of acetonitrile, water, trifluoroacetic acid and ammonium acetate was used in combination with a gradient elution system to retain glucosamine hydrochloride, chondroitin sulfate, calcium and curcumin in the chromatogram, and the separation degree of each component was between 6.9 and 11.7.

[0139] If only acetonitrile-water mixed solvent is used for elution, most of the components in the chromatogram are not retained; if only acetonitrile, water, and trifluoroacetic acid mixed solvent is used for elution, some of the component peaks will overlap, and the separation effect is worse than that described in (iv) in the technical scheme of Example 1; if only acetonitrile, water, and ammonium acetate mixed solvent is used for elution, some of the components are not retained, and the effect is worse than that described in (iv) in the technical scheme of Example 1. See Table 1. The results show that if the mobile phase components are only two or three of acetonitrile, water, trifluoroacetic acid, and ammonium acetate, it is impossible to achieve simultaneous determination of glucosamine hydrochloride, chondroitin sulfate, calcium, and curcumin.

[0140] Table 6 Investigation of mobile phase and elution conditions

[0141]

[0142] Example 4

[0143] Comparison of different detectors

[0144] (i) The reference substance mixture in step (iv) of Example 1 was tested according to the detector parameters recorded in Table 7, and the remaining condition parameters were the chromatographic conditions of step (ii) of Example 1.

[0145] (ii) Calcium has no ultraviolet absorption and no chromatographic peak is retained in the ultraviolet detector. Therefore, when investigating different detectors, the commonly used ultraviolet detector is not considered. Only the electrospray detector and the evaporative light scattering detector are considered. The specific chromatographic conditions are described in Table 7.

[0146] Table 7 Detector conditions

[0147]

[0148] Accurately pipette 10 μL of sample solution and inject it into the HPLC according to the conditions in Table 7. Record the chromatogram and observe the number of components detected in the chromatogram and the separation between the components. Figure 2 ), the peak order of the four active ingredients in glucosamine chondroitin calcium tablets is curcumin, chondroitin sulfate, glucosamine hydrochloride, and calcium, and the minimum separation between the peaks reaches 6.9. The chromatogram of the evaporative light scattering detector is shown in Figure 3 As can be seen from the figure, only three main peaks are retained in the reference mixture, so it is feasible to select an electrospray ionization detector to separate and detect the four active ingredients in glucosamine chondroitin calcium tablets.

[0149] Example 5

[0150] Comparison of different chromatographic columns

[0151] (i) Prepare a reference sample mixture according to (iv) in Example 1.

[0152] (ii) Curcumin, chondroitin sulfate, glucosamine hydrochloride, and calcium are all highly polar substances, so the normal phase liquid separation system is not applicable. In the reverse phase liquid separation system, high polar substances have low retention in the C18 column and are mostly flushed out near the solvent peak, and the separation effect is not good, so they are not considered. The hydrophilic interaction chromatography column (HILIC) is one of the hot topics in the field of chromatography research in recent years. It uses a highly polar stationary phase and combines a mobile phase composed of a high proportion of organic phase / a low proportion of aqueous phase to achieve the separation of highly polar substances. It is particularly suitable for separating polar compounds that are not retained in reverse phase columns and has a high sensitivity to them. The inventors have examined multiple categories of Hilic chromatographic columns, and only the chromatographic column described in the technical solution (iv) of Example 1 can achieve the retention and separation of four components under the gradient elution described in the solution. See the attached chromatograms of number 2 to number 4. Figures 4 to 6 .

[0153] Table 8 Comparison of chromatographic columns

[0154]

[0155] Example 6

[0156] Determination of pre-treatment method

[0157] (I) Determination of organic solvent for pretreatment

[0158] Take 30 tablets of glucosamine chondroitin calcium tablets with batch number S240102, place them in a mortar and grind them into uniform powder, accurately weigh 3 samples, each sample is 0.15g, and place them in 100mL volumetric flasks, respectively, and use 95% ethanol, methanol, and acetonitrile as extraction solvents, respectively. Other conditions are the same as those in the technical scheme of Example 1 (i). Samples are injected according to the chromatographic conditions of the technical scheme of Example 1 (ii), and the peak areas of curcumin, chondroitin sulfate, glucosamine hydrochloride, and calcium are recorded in turn. The results are shown in Table 9.

[0159] Table 9 Pretreatment organic solvent investigation results (unit: peak area)

[0160]

[0161] As can be seen from Table 9, the extraction efficiencies of the three are comparable, and 95% ethanol is preferred due to its low toxicity and low price.

[0162] (II) Determination of acid type in pretreatment

[0163] Take 30 glucosamine chondroitin calcium tablets with batch number S240102, place them in a mortar and grind them into uniform powder, accurately weigh 4 samples, each sample is 0.15g, place them in a 10mL volumetric flask, add 30mL of 95% ethanol, gently shake to disperse the samples evenly, add 2mL of glacial acetic acid to the first sample, add 2mL of phosphoric acid to the second sample, add 2mL of hydrochloric acid to the third sample, and do not add acid to the fourth sample. Add about 50mL of water to the four samples, shake them gently, extract them with ultrasound (500w, 5min), take them out and put them at room temperature, make up to volume with water, shake them well, and obtain 4 sample solutions. Observe the appearance of the solution and record it, inject the sample according to the chromatographic conditions of (ii) in the technical scheme of Example 1, and observe the peak types of curcumin, chondroitin sulfate, glucosamine hydrochloride, and calcium in turn. The results are shown in Table 10.

[0164] Table 10 Results of investigation on pretreatment acid types

[0165]

[0166] The purpose of adding acid appropriately is to dissolve calcium carbonate in the sample and make calcium exist in the form of ions. However, too strong an acid will destroy other components. From the appearance of the solution, we know that acetic acid and hydrochloric acid can dissolve calcium carbonate. From the data in Table 10, we know that hydrochloric acid is too strong, which makes the peak shape of glucosamine hydrochloride worse. See the attached data for details. Figure 7 Therefore, glacial acetic acid is the most suitable for extracting samples.

[0167] (III) Determination of acid solution concentration in pretreatment

[0168] Take 30 tablets of glucosamine chondroitin calcium tablets with batch number S240102, place them in a mortar and grind them into uniform powder, accurately weigh 4 samples, 0.15g of each sample, place them in a 100mL volumetric flask, add 30mL of 95% ethanol, and gently shake the samples to make them evenly dispersed. Add 1mL of glacial acetic acid to the first sample, 2mL of glacial acetic acid to the second sample, 3mL of glacial acetic acid to the third sample, and 4mL of glacial acetic acid to the fourth sample. Add about 50mL of water to the four samples and shake them gently, then use ultrasonic extraction (500w, 5min), take them out and put them at room temperature, make up to volume with water, shake them well, and obtain four sample solutions. Observe the appearance of the solution and record it. Inject the sample according to the chromatographic conditions of (ii) in the technical scheme of Example 1, and observe the peak types of curcumin, chondroitin sulfate, glucosamine hydrochloride, and calcium in turn. The results are shown in Table 11.

[0169] Table 11 Determination of pretreatment acid solution concentration

[0170]

[0171] From the data in Table 11, it can be seen that when the amount of glacial acetic acid added is 1mL, the solution is turbid, the solubility of calcium is poor, and the calcium peak is small. When the amount of glacial acetic acid added is in the range of 2mL to 4mL, it has little effect on sample determination, but excessive acid concentration will affect the service life of the chromatographic column. Therefore, the minimum value is selected, and the amount of glacial acetic acid added per portion is 2mL, which not only meets the sample reaction needs, but also prolongs the service life of the chromatographic column and saves costs.

[0172] (V) Determination of the ratio of organic solvent, acid and water in pretreatment

[0173] Take 30 glucosamine chondroitin calcium tablets with batch number S240102, place them in a mortar and grind them into uniform powder, accurately weigh 3 samples, 0.15 g of each sample, place them in a 100 mL volumetric flask, add 20 mL of 95% ethanol to the first sample, add 30 mL of 95% ethanol to the second sample, and add 40 mL of 95% ethanol to the third sample, shake gently to make the sample evenly dispersed, add 2 mL of glacial acetic acid and 50 mL of water, shake gently, extract with ultrasound (500w, 5min), take out and put it at room temperature, make up to volume with water, shake well, and obtain 3 sample solutions, observe the appearance of the solution and record it, inject the sample according to the chromatographic conditions of (ii) in the technical scheme of Example 1, and observe the peak areas of curcumin, chondroitin sulfate, glucosamine hydrochloride, and calcium in turn. The results are shown in Table 12.

[0174] Table 12 Determination of the ratio of organic solvent to acid solution in pretreatment

[0175]

[0176] From the data in Table 12, it can be seen that the greater the proportion of ethanol added, the lower the response values ​​of chondroitin sulfate, glucosamine hydrochloride, and calcium become; the greater the proportion of the aqueous phase, the lower the response value of curcumin becomes; and the proportion of sample 2 is comprehensively selected.

[0177] Example 7

[0178] The measured data of multiple batches of samples were compared using the existing method and the method of Example 1:

[0179] Take four batches of Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. The samples of glucosamine chondroitin calcium tablets were respectively determined according to GB 5009.92-2016 National Food Safety Standard Determination of Calcium in Food, using the third method - inductively coupled plasma emission spectrometry to determine the calcium content; the glucosamine hydrochloride and chondroitin sulfate contents were determined according to GB / T 20365-2006 Determination of Chondroitin Sulfate and Glucosamine Hydrochloride Contents - Liquid Chromatography; and the curcumin content was determined by the first method - high performance liquid chromatography according to SN / T 4890-2017 Determination of Curcumin in Export Foods - High Performance Liquid Chromatography and Liquid Chromatography-Mass Spectrometry / Mass Spectrometry. The results of the four components were compared with the measured values ​​of the present invention, and the specific results are shown in Table 13, in g / 100g.

[0180] Table 13 Method comparison results (unit: g / 100g)

[0181]

[0182] From the test results, it can be seen that the test results of the method in Example 1 are not much different from those of the existing authoritative method, and the test results are in line with the internal control standards of the enterprise. Therefore, the present invention can be used as a means of product production process and product online quality control, providing data support for the industrialization of products and providing a basis for the establishment of product quality standards.

[0183] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein by equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for simultaneously detecting curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium, characterized in that: It includes separation of curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium by high performance liquid chromatography; HPLC conditions included: The chromatographic column uses a chromatographic column whose stationary phase has a hydrophilic effect; The mobile phase system includes mobile phase A and mobile phase B; The mobile phase A is composed of acetonitrile, water and trifluoroacetic acid, and the concentrations of acetonitrile, water and trifluoroacetic acid in the mobile phase A are equivalent to the concentrations of acetonitrile, water and trifluoroacetic acid in a system in which acetonitrile and 0.15% v / v trifluoroacetic acid aqueous solution are mixed in a volume ratio of (75-80): (20-25); The mobile phase B is composed of acetonitrile, water and ammonium acetate, and the concentrations of acetonitrile, water and ammonium acetate in the mobile phase B are equivalent to the concentrations of acetonitrile, water and ammonium acetate in a system in which acetonitrile and 0.5% w / v ammonium acetate aqueous solution are mixed in a volume ratio of (15-20):(75-85); According to the gradient elution, the elution program is: At 0 to 2 minutes, the initial volume ratio of the mobile phase A to the mobile phase B is (90 to 99): (1 to 10); At 2.1-7 min, the volume ratio of the mobile phase A to the mobile phase B changes from (90-99):(1-10) to (70-75):(25-30); At 7.1-12 min, the volume ratio of the mobile phase A to the mobile phase B changes from (70-75):(25-30) to (90-99):(1-10); At 12.1-18 min, the volume ratio of the mobile phase A to the mobile phase B is maintained at (90-99):(1-10); The detector of the liquid chromatograph is an electrospray detector.

2. The method according to claim 1, characterized in that The mobile phase A consists of acetonitrile, water and trifluoroacetic acid, and the concentrations of acetonitrile, water and trifluoroacetic acid in the mobile phase A are equivalent to the concentrations of acetonitrile, water and trifluoroacetic acid in a system in which acetonitrile and 0.15% v / v trifluoroacetic acid aqueous solution are mixed in a volume ratio of 78:22; and / or, The mobile phase B consists of acetonitrile, water and ammonium acetate, and the concentrations of acetonitrile, water and ammonium acetate in the mobile phase B are equivalent to the concentrations of acetonitrile, water and ammonium acetate in a system in which acetonitrile and 0.5% w / v ammonium acetate aqueous solution are mixed in a volume ratio of 20:80; Optionally, mobile phase A consists of acetonitrile and 0.15% v / v trifluoroacetic acid aqueous solution, the volume ratio of acetonitrile and 0.15% v / v trifluoroacetic acid aqueous solution is 78:22; mobile phase B consists of acetonitrile and 0.5% w / v ammonium acetate aqueous solution, the volume ratio of acetonitrile and 0.5% w / v ammonium acetate aqueous solution is 20:80; Optionally, elution is performed according to a gradient, the elution program being: At 0 to 2 minutes, the initial volume ratio of the mobile phase A to the mobile phase B is 95:5; At 2.1 to 7 minutes, the volume ratio of the mobile phase A to the mobile phase B changed from 95:5 to 72:28; At 7.1 to 12 min, the volume ratio of the mobile phase A to the mobile phase B changed from 72:28 to 95:5; At 12.1 to 18 min, the volume ratio of the mobile phase A to the mobile phase B was maintained at 95:5; Optionally, the volume ratio of the mobile phase A to the mobile phase B in any step changes at a linear uniform speed.

3. The method according to claim 1, characterized in that The flow rate of the gradient elution is 0.9-1.1 mL / min; Optionally, the injection volume is 10 μL; Optionally, the column temperature of the chromatographic column is 38-42°C.

4. The method according to claim 1, characterized in that: The parameters of the electrospray detector were: data acquisition frequency 10 Hz, filtering 5.0 s, nebulizer temperature control High, power function 1, and gas pressure 65.2 psi.

5. The method according to claim 1, characterized in that The chromatographic column is a YMC-Triart Diol-HILIC liquid chromatography column with a specification of 4.6×250 mm and 5 μm.

6. The method according to claim 1, characterized in that The contents of curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium were analyzed and calculated by the external standard method; Optionally, the external standard method is a standard curve method.

7. The method according to claim 1, characterized in that The samples to be tested include nutritional supplements containing curcumin, chondroitin sulfate, glucosamine hydrochloride, and calcium; Optionally, the nutritional supplement is in the form of tablets, and the auxiliary materials include low-substituted hydroxypropyl cellulose, povidone K30 and microcrystalline cellulose.

8. The method according to any one of claims 1 to 7, characterized in that: The calcium in the sample to be tested is provided by calcium carbonate. The method further comprises pre-treating the sample, wherein the pre-treating comprises extracting the analyte in the sample to be tested using an extraction reagent; the extraction reagent comprises an organic phase, an acid and water; Optionally, the organic phase comprises one or more of ethanol, methanol and acetonitrile; Optionally, the organic phase comprises 95% v / v ethanol; Optionally, the acid includes one or more of glacial acetic acid, phosphoric acid and hydrochloric acid; Optionally, the extraction reagent includes 95% v / v ethanol, glacial acetic acid and water, and the ratio of the sample to be tested, 95% v / v ethanol, glacial acetic acid and water is 0.15 g: 20-50 mL: 2-4 mL: 50 mL.

9. The method according to claim 8, characterized in that The pretreatment includes mixing the sample to be tested with the organic phase, adding acid and water, extracting by shaking, filtering and taking the filtrate to obtain the test solution; Optionally, the vibration extraction is ultrasonic extraction; Optionally, the output power of the ultrasonic extraction is 500w and the time is 5min.

10. Use of the method for simultaneously detecting curcumin, chondroitin sulfate, glucosamine hydrochloride and calcium according to any one of claims 1 to 9 in the preparation of nutritional supplements.